Sentient Brands Holdings Inc.

SNBH

US81728V1026

Pharmaceuticals

Delayed OTC Markets Other stock markets 09:35:06 24/05/2024 pm IST			5-day change	1st Jan Change
0.058 ^USD	-7.94%		-21.62%	-47.27%

16/04	Sentient Brands Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Sentient Brands Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Intelligent Buying, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020

June 01, 2020 at 02:55 am IST

Intelligent Buying, Inc. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was USD 6,783 compared to USD 0 a year ago. Operating loss was USD 304,095 compared to USD 49,497 a year ago. Net loss was USD 355,459 compared to USD 49,497 a year ago. Basic loss per share from continuing operations was USD 0.048 compared to USD 0.007 a year ago.

Latest news about Sentient Brands Holdings Inc.

Sentient Brands Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	17/04	CI
Sentient Brands Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	21/11	CI
Sentient Brands Holdings Inc. entered into a Letter of Intent to acquire portfolio of alcohol and non-alcoholic beverage, confectionery, and baking goods businesses from American Industries, Inc.	22/23/22	CI
Sentient Brands Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/23/22	CI
Sentient Brands Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23/23/23	CI
Sentient Brands Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	18/23/18	CI
Sentient Brands Holdings Inc. Auditor Raises 'Going Concern' Doubt	17/23/17	CI
Sentient Brands Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22/22/22	CI
Sentient Brands Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	23/22/23	CI
Sentient Brands Holdings Inc. Announces Management Changes	25/22/25	CI
Sentient Brands Holdings Inc. Announces CFO Changes	25/22/25	CI
Sentient Brands Holdings Inc. Announces CEO Changes	25/22/25	CI
Sentient Brands Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	23/22/23	CI
Sentient Brands Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	29/22/29	CI
Sentient Brands Holdings Inc. Auditor Raises 'Going Concern' Doubt	29/22/29	CI
Sentient Brands Holdings Inc. Launches Its "Oeuvre Skincare" Luxury Product Line	08/21/08	CI
Sentient Brands Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	23/21/23	CI
Sentient Brands Holdings Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	24/21/24	CI
Sentient Brands Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	18/21/18	CI
Sentient Brands Holdings Inc. announced that it has received funding from Leonite Capital LLC	27/21/27	CI
Sentient Brands Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	16/21/16	CI
Intelligent Buying, Inc. has Changed its Name to Sentient Brands Holdings Inc	02/21/02	CI
Intelligent Buying, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	24/20/24	CI
Intelligent Buying, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	15/20/15	CI
Intelligent Buying, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	01/20/01	CI

Chart Sentient Brands Holdings Inc.

Duration

Period

More charts

Company Profile

Sentient Brands Holdings Inc. is a product development and brand management company. The Company focuses on building brands in the luxury and premium market space. It has a direct-to consumer business model focusing on the integration of cannabidiol (CBD), wellness, and beauty for consumers. It develops and supports lifestyle brands through-out-ingredients, packaging, fragrance, and design. It is focused on two market segments: wellness and luxury. Its product line is Oeuvre, which is a CBD luxury skin care line and lifestyle brand. Oeuvre's product offerings include Purifying Exfoliator, Replenishing Facial Oil, Ultra-Nourishing Face Cream, and Revitalizing Eye Cream. Oeuvre products are non-toxic, ungendered products made with zero GMO, retinyl palmitate, petroleum, mineral oil, parabens, sulfates, and synthetic colors. Its products are accessible across digital and retail channels. Its customers include artists, beauty, influencers, bloggers, wellness audiences, and makeup artists.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
SENTIENT BRANDS HOLDINGS INC.	-47.27%	37.33L
DONG-E-E-JIAO CO.,LTD.	+43.17%	603.67Cr
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-20.16%	427.46Cr
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+7.40%	327.6Cr
TASLY PHARMACEUTICAL GROUP CO., LTD	-15.80%	296.01Cr
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-4.70%	242.78Cr
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+48.28%	193.03Cr
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-11.60%	159.24Cr
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-3.02%	157.61Cr
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.62%	149.75Cr